Decreased CD4CD8 T cells in early HIV infection are associated with rapid disease progression.

Cytokine

NHC Key Laboratory of AIDS Immunology (China Medical University), Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China; Key Laboratory of AIDS Immunology of Liaoning Province, The First Affiliated Hospital of China Medical University, Shenyang 110001, China; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang 110001, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, 79 Qingchun Street, Hangzhou 310003, China. Electronic address:

Published: January 2020

Background: HIV rapid progressors (RPs) present with a rapid decline of CD4 T cells within a few years of infection. Determining the underlying mechanisms throughout this decline is important to identify prognostic biomarkers and intervention strategies. Determining the numbers of CD4 and CD8 T cells is essential for monitoring the immune status of HIV infected patients. There are additional kinds of cell subtypes in T cells, but their relationship to the rapid progression of HIV disease is not well defined.

Methods: Nineteen RPs and twenty-one chronic progressors (CPs) were enrolled in this study. Based on the intensity of CD4 and CD8 expression, different T cell subtypes were identified, including CD4CD8T cells, CD4CD8 T cells, CD4CD8 T cells and CD4CD8 T cells. Alterations in these T cell subtypes in early HIV infection (within 120 days of infection) between RPs and CPs were measured, and the relationships between these subtypes and HIV disease progression were investigated. In addition, expression of IFN-γ in T cell subtypes after PMA stimulation was analyzed by flow cytometry.

Results: We found that during early HIV infection, CD4CD8 T cells both significantly decreased in numbers and percentages in RPs compared to CPs. Furthermore, baseline CD4CD8 T cells positively correlated not only with baseline CD4T cells but also with CD4T cells 12 months after infection. Moreover, survival analysis indicated that low levels of baseline CD4CD8low T cells significantly accelerated the decline in CD4 T cells as well as increased viral loads. CD4CD8 T cells secreted significantly more IFN-γ after PMA stimulation compared to CD4CD8T cells and CD4CD8T cells, which may be beneficial for the prevention of disease progression.

Conclusions: Our results identified that in early stage HIV-1 infection, a subtype of T cells, CD4CD8, are associated with subsequent disease progression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2019.154801DOI Listing

Publication Analysis

Top Keywords

cd4cd8 cells
28
cells
18
cell subtypes
16
cells cd4cd8
16
early hiv
12
hiv infection
12
disease progression
12
cd4cd8t cells
12
decline cd4
8
cd4 cells
8

Similar Publications

Unlabelled: Cytomegalovirus (CMV) is a human herpes virus with a worldwide seroprevalence of 60-100%, mainly known to cause severe life-threatening disease in immunocompromised patients. In immunocompetent hosts (IMCh), CMV causes a self-limiting mononucleosis-like infection, and severe pictures are less recognized. We report a case of a previously healthy 62-year-old woman evaluated in the Internal Medicine outpatient clinic for 3 weeks of progressive fatigue, generalised inflammatory arthralgias, hypogastric discomfort and daily persistent fever.

View Article and Find Full Text PDF

Oral Kaposi sarcoma in Brazil: a case series of 40 patients highlighting a significant health burden.

Oral Surg Oral Med Oral Pathol Oral Radiol

December 2024

Oral Diagnosis Department, Piracicaba Dental School, University of Campinas, Piracicaba, Brazil; Service of Oral Pathology, João de Barros Barreto University Hospital, Federal University of Pará, Pará, Brazil. Electronic address:

Objective: The aim of this study was to provide a comprehensive clinicopathological analysis of oral Kaposi sarcoma (KS) cases and examine its relationship with HIV-related immunosuppression.

Study Design: Paraffin-embedded tissue blocks of patients microscopically diagnosed with oral KS were retrieved from three oral and maxillofacial pathology files. Data including clinical, laboratory, microscopic and immunohistochemical findings and treatment employed were retrieved.

View Article and Find Full Text PDF

How do immune cells shape type 1 diabetes? Insights from Mendelian randomization.

Front Endocrinol (Lausanne)

January 2025

School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.

Objective: The role of immune cells in type 1 diabetes (T1D) is unclear. The aim of this study was to assess the causal effect of different immune cells on T1D using Mendelian randomization (MR).

Methods: A dataset of immune cell phenotypes (numbered from GCST0001391 to GCST0002121) was obtained from the European Bioinformatics Institute, while a T1D dataset (numbered finngen_R10_T1D) was obtained from FinnGen.

View Article and Find Full Text PDF

Introduction: Gallstone may cause complications of cholecystitis, gallbladder gangrene, perforation, and related sepsis. This study aims to identify how CRP and immune cells change in patients with acute calculous cholecystitis based on the severity of disease.

Method: Patients with acute calculous cholecystitis were categorized into three main groups-mild, moderate, and severe-based on the Tokyo guidelines.

View Article and Find Full Text PDF

BICSTaR (BICtegravir Single Tablet Regimen) is an ongoing, observational cohort study assessing the virologic effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-experienced (TE) and treatment-naïve (TN) people with HIV across 14 countries over 24 months. We present 12-month outcomes from participants in the BICSTaR Japan cohort. Retrospective and prospective data were pooled from people with HIV aged ≥20 years receiving B/F/TAF within routine clinical care in Japan.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!